Works matching IS 02533766 AND DT 2025 AND VI 47 AND IP 5

Results: 9

基于前瞻性队列的高危型人乳头瘤病毒分型检测在宫颈癌筛查中的效果评价.

Published in:

Chinese Journal of Oncology, 2025, v. 47, n. 5, p. 435, doi. 10.3760/cma.j.cn112152-20240219-00079

By:

王红;
刘茵;
徐慧芳;
陈佩佩;
孙星媛;
李梦洁;
李佩瑶;
李堃垚;
郑黎阳;
刘曙正;
孙喜斌;
乔友林;
张韶凯

Publication type:

Article

新疆维吾尔自治区 503 例恶性黑色素瘤患者的临床特征及预后分析.

Published in:

Chinese Journal of Oncology, 2025, v. 47, n. 5, p. 426, doi. 10.3760/cma.j.cn112152-20240904-00382

By:

杜俊炜;
张强;
孙亚超;
何海洋;
麦尔旦江·麦合木提;
籍素芝;
戴志兵;
江仁兵

Publication type:

Article

PD-1 抑制剂联合化疗治疗根治性放化疗后原位复发食管鳞状细胞癌的疗效和安全性.

Published in:

Chinese Journal of Oncology, 2025, v. 47, n. 5, p. 418, doi. 10.3760/cma.j.cn112152-20240805-00327

By:

施禹西;
李慧;
周雷;
郭依玉;
葛东方;
徐新宇;
白晨光;
张治;
周国仁;
叶劲军

Publication type:

Article

通过术前降钙素水平预测甲状腺髓样癌上纵隔淋巴结转移的临床价值.

Published in:

Chinese Journal of Oncology, 2025, v. 47, n. 5, p. 411, doi. 10.3760/cma.j.cn112152-20240710-00284

By:

李瀚;
宋艺璇;
宁玉东;
刘绍严

Publication type:

Article

CYP2D6*10 基因多态性与他莫昔芬治疗乳腺癌相关不良反应的关联性研究.

Published in:

Chinese Journal of Oncology, 2025, v. 47, n. 5, p. 404, doi. 10.3760/cma.j.cn112152-20240613-00251

By:

朱倩男;
王若曦

Publication type:

Article

靶向间皮素载紫杉醇相变纳米粒治疗卵巢癌的实验研究.

Published in:

Chinese Journal of Oncology, 2025, v. 47, n. 5, p. 395, doi. 10.3760/cma.j.cn112152-20240701-00270

By:

罗丽;
万钰洁;
许馨之;
王娜;
李芳;
周航

Publication type:

Article

纳米抗体工程化外泌体递送 miR-204-5p 靶向治疗结直肠癌的实验研究.

Published in:

Chinese Journal of Oncology, 2025, v. 47, n. 5, p. 385, doi. 10.3760/cma.j.cn112152-20231024-00211

By:

龚亮;
田璐;
李艳春;
吴志猛;
黄朝晖

Publication type:

Article

乳腺力医学.

Published in:

Chinese Journal of Oncology, 2025, v. 47, n. 5, p. 363, doi. 10.3760/cma.j.cn112152-20240414-00148

By:

杨谨;
赵希文;
高欢;
程波;
徐峰

Publication type:

Article

中国 2013—2021 年女性乳腺癌死亡率的变化趋势分析.

Published in:

Chinese Journal of Oncology, 2025, v. 47, n. 5, p. 376, doi. 10.3760/cma.j.cn112152-20240530-00227

By:

高婷;
李超;
姚一菲;
杨剑;
梁锌

Publication type:

Article